Targeting p53 Y220C: Dr Dale Shepard Discusses Rezatapopt FindingsBySabrina Serani,Dale Shepard, MD, PhDApril 2nd 2026
FDA Grants Breakthrough Therapy Designation to Plixorafenib for BRAF V600E GliomaBySabrina SeraniApril 2nd 2026